Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Insomnia In Women With Breast Cancer Linked To Heart Rate Dysregulation
http://www.medicalnewstoday.com/articles/125733.php
A study in the October 15 issue of the <i>Journal of Clinical Sleep Medicine</i> shows that respiratory sinus arrhythmia (RSA) is a significant predictor of insomnia in women with breast cancer and confirmed that longer nocturnal wake episodes were associated with a flatter diurnal cortisol slope.
Breast Cancer - Data Show Synergistic Activity Of Telomerase Inhibitor Drug And Trastuzumab On Inhibiting Cell Growth
http://www.medicalnewstoday.com/articles/125724.php
Geron Corporation (Nasdaq:GERN) today announced the publication of preclinical data demonstrating that its telomerase inhibitor drug, GRN163L, significantly boosts the effects of trastuzumab (Herceptin™) against HER2-positive breast cancer cells and restores sensitivity to trastuzumab in trastuzumab resistant tumor cells.
Europa Donna - The European Breast Cancer Coalition Holding Media Event To Launch First Breast Health Day On 15 October
http://www.medicalnewstoday.com/articles/125687.php
The European Breast Cancer Coalition's Media Event to announce the first Breast Health Day on 15 October 2008 will feature EU Commissioner for Health Androulla Vassiliou, International Agency for Research on Cancer Director Prof.
Women Need To Be Aware Of Changes, IU Simon Cancer Center Breast Expert Says
http://www.medicalnewstoday.com/articles/125658.php
Every day, women face a barrage of headlines about breast cancer. What should they do with all of that information? George Sledge, M.D., an internationally recognized breast cancer expert, pointed out that, despite all of the near-constant news and information about breast cancer, it is not the disease that impacts most women.
Women Needed For Breast Cancer Prevention Trial, Manchester, England
http://www.medicalnewstoday.com/articles/125621.php
Manchester women at high risk of developing breast cancer are being urged to take part in a pioneering research programme into the prevention of the disease. <a href="http://www.genesisuk.org" target="_blank" rel="nofollow">The Genesis Appeal</a>, the UK's only charity dedicated entirely to the prevention of breast cancer, is recruiting women to take part in the International Breast Cancer Intervention Study (IBIS II).
Positive Results From Clinical Study Designed To Evaluate Efficacy Of Circulating Tumor Cell Detection With Ikonisys' Automated Microscope
http://www.medicalnewstoday.com/articles/125613.php
Ikonisys, a leading provider of next-generation, cell-based diagnostic solutions, today announced positive results from a clinical study conducted by a research group at the Weatherall Institute of Molecular Medicine at Oxford University, a laboratory supported by Cancer Research U.
New Tool In The Early Detection Of Breast Cancer
http://www.medicalnewstoday.com/articles/125592.php
Avie Products announced the introduction of a unique new product in the fight against breast cancer called "Cue." The waterproof electronic device, which reminds women, in the privacy of their showers, to perform regular breast self-exams, is being fully launched in the US this month to coincide with National Breast Cancer Awareness Month.
----------------------------------------------
** CANCER / ONCOLOGY News **
ZIOPHARM Receives Orphan Medicinal Product Designation For Palifosfamide (ZIO-201) In The Treatment Of Soft Tissue Sarcoma
http://www.medicalnewstoday.com/articles/125731.php
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), announced today that the European Medicines Agency's (EMEA) Committee for Orphan Medicinal Products (COMP) has issued a positive opinion regarding ZIOPHARM's application for orphan medicinal product designation for palifosfamide in the treatment of soft tissue sarcoma (STS).
Breast Cancer - Data Show Synergistic Activity Of Telomerase Inhibitor Drug And Trastuzumab On Inhibiting Cell Growth
http://www.medicalnewstoday.com/articles/125724.php
Geron Corporation (Nasdaq:GERN) today announced the publication of preclinical data demonstrating that its telomerase inhibitor drug, GRN163L, significantly boosts the effects of trastuzumab (Herceptin™) against HER2-positive breast cancer cells and restores sensitivity to trastuzumab in trastuzumab resistant tumor cells.
Genetic Analysis Predicts Whether Liver Cancer Likely To Recur
http://www.medicalnewstoday.com/articles/125723.php
Researchers are poised to unlock the genetic secrets stored in hundreds of thousands of cancer biopsy samples locked in long-term storage and previously thought to be useless for modern genetic research.
FDA Grants Orphan Drug Status To Reata's RTA 402 For Treatment Of Pancreatic Cancer
http://www.medicalnewstoday.com/articles/125718.php
Reata Pharmaceuticals, Inc. announces that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. RTA 402 is currently being studied in a Phase 1/2 trial in patients with pancreatic cancer, and is also in Phase 2 development for chronic kidney disease.
Biothera Initiates Second Arm Of Metastatic Colorectal Cancer Trial
http://www.medicalnewstoday.com/articles/125716.php
Biothera announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August. This arm of the trial is evaluating the combination therapy of its lead drug candidate, Imprime PGG®, with Erbitux®, an anti-cancer monoclonal antibody from ImClone Systems.
Breakthrough Cancer Pain - Archimedes Pharma Announces First Positive Phase III Clinical Trial Results For NasalFent
http://www.medicalnewstoday.com/articles/125710.php
Archimedes Pharma Limited, the UK based, pan-European specialty pharmaceutical company, today announces positive headline Phase III results for NasalFent®, the Company's innovative fentanyl citrate nasal spray, developed to provide fast, effective and convenient treatment for breakthrough cancer pain.
AACR And Pancreatic Cancer Action Network Provide Over $1.2 Million In Funds For Pancreatic Cancer Research
http://www.medicalnewstoday.com/articles/125699.php
The American Association for Cancer Research is accepting applications for grants supporting pancreatic cancer research. The deadline for applications is November 10, 2008. The grant terms will begin on July 1, 2009.
Scientists Close In On Method To Fight Deadly Childhood Cancer - Blocking The Growth Of Neuroblastoma
http://www.medicalnewstoday.com/articles/125653.php
A multicenter team of researchers, including scientists from the University of Florida, has discovered a way to potentially block the growth of neuroblastoma, a type of cancer responsible for 15 percent of all cancer deaths in children.
Scientists Close In On Method To Fight Deadly Childhood Cancer
http://www.medicalnewstoday.com/articles/125644.php
A multicenter team of researchers, including scientists from the University of Florida, has discovered a way to potentially block the growth of neuroblastoma, a type of cancer responsible for 15 percent of all cancer deaths in children.
Stem Cell Sentry Sounds The Alarm To Maintain Balance Between Cancer And Aging
http://www.medicalnewstoday.com/articles/125599.php
Like a sentry guarding the castle walls, a molecular messenger inside adult stem cells sounds the alarm when it senses hazards that could allow the invasion of an insidious enemy: Cancer.The alarm bell halts the process of cell division in its tracks, preventing an error that could lead to runaway cell division and eventually, tumor formation.
Provectus Announces First Peer-Reviewed Publication On PV-10 In "Melanoma Research"
http://www.medicalnewstoday.com/articles/125593.php
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced that "Melanoma Research" has published a paper entitled, "Chemoablation of metastatic melanoma using intralesional Rose Bengal," on its website.
Get The Facts About Genetic Testing For Cancer
http://www.medicalnewstoday.com/articles/125589.php
With so much information in the news these days about genetic testing for cancer, how do you know if you should get tested? Or what kind of test to get, or whether it's covered by your insurance?"The availability of genetic tests, especially in the area of predicting your risk of getting cancer, is increasing.
Cancer Screenings Are Available For Many, But Not Used
http://www.medicalnewstoday.com/articles/125566.php
Medicaid recipients age 50 and older are falling short of nationalcancer screening objectives. According to a report published in theOctober 13 issue of <i>Archives of Internal Medicine</i>,only about half receive colorectal, breast, and cervical cancerscreening tests that the government recommends.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
UQ's Cervical Cancer Vaccine Co-creator Professor Ian Frazer Has Won The 2008 Prime Minister's Prize For Science - Australia
http://www.medicalnewstoday.com/articles/125703.php
Professor Frazer, Director of <a href="http://www.di.uq.edu.au" target="_blank" rel="nofollow">UQ's Diamantina Institute for Cancer, Immunology and Metabolic Medicine</a>, was presented with his prize by Prime Minister Kevin Rudd at a special ceremony in the Great Hall, Parliament House Canberra tonight (Thursday, October 16) .
----------------------------------------------
** COLORECTAL CANCER News **
Biothera Initiates Second Arm Of Metastatic Colorectal Cancer Trial
http://www.medicalnewstoday.com/articles/125716.php
Biothera announced today it began dosing patients in the second arm of its metastatic colorectal cancer (mCRC) trial in August. This arm of the trial is evaluating the combination therapy of its lead drug candidate, Imprime PGG®, with Erbitux®, an anti-cancer monoclonal antibody from ImClone Systems.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
ZIOPHARM Receives Orphan Medicinal Product Designation For Palifosfamide (ZIO-201) In The Treatment Of Soft Tissue Sarcoma
http://www.medicalnewstoday.com/articles/125731.php
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), announced today that the European Medicines Agency's (EMEA) Committee for Orphan Medicinal Products (COMP) has issued a positive opinion regarding ZIOPHARM's application for orphan medicinal product designation for palifosfamide in the treatment of soft tissue sarcoma (STS).
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Prostate Cancer Gene Test Provides New Early Detection - Urine Test May Reduce Needless And Expensive Biopsies
http://www.medicalnewstoday.com/articles/125662.php
Prostate cancer (PCa) is one of the most common male cancers in the Western world. Currently, early detection of PCa depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often associated with anxiety, discomfort, complications, and heavy expenses.
Phase I Clinical Trial Of ImmuFact IMP321 In Pancreatic Cancer Will Be Carried Out At Washington University In Saint Louis
http://www.medicalnewstoday.com/articles/125643.php
Immutep S.A. announced today that the FDA, after review of the Investigational New Drug Application (IND), has allowed the administration of IMP321 in cancer patients in a Phase I trial conducted by Dr.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment